Tonix Pharmaceuticals Holding Corp. Releases Preliminary Year-End 2024 Financial Results
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) recently published selected preliminary operating results and financial condition information for the year ending December 31, 2024. The company disclosed that it held approximately $98.8 million in cash and cash equivalents as of December 31, 2024, which is anticipated to sustain planned operations well into the first quarter of […]
More Stories
What Battleground Voters Are Saying About Healthcare Affordability
By Lawrence Wilson “Yes, I do have opinions about this,” said Milwaukee resident Addaru Valentine just after voting in Wisconsin’s...
UAE Accuses Iran of Attacking Abu Dhabi National Oil Company Vessel in Strait of Hormuz
By Jacki Thrapp The United Arab Emirates (UAE) accused the Iranian regime of attacking an Abu Dhabi National Oil Company...
Federal Judge Declines to Block Border Wall Construction on Arizona Tribal Land
By Aldgra Fredly A federal judge on Aug. 14 refused to block the Trump administration from building a border wall...
Wall Street Review: S&P 500 Hits Record High as Inflation Cools, Earnings Stay Strong
By Panos Mourdoukoutas The S&P 500 climbed to a fresh record high this week, powered by new data showing inflation...
Fauci Refuses to Appear Before 2nd Senate Panel After Contempt Vote
By Tom Ozimek Dr. Anthony Fauci has declined a request to appear voluntarily before a second Senate panel, days after...
HHS Report on Alleged Pediatric Gender-Treatment Fraud: 5 Key Takeaways
By Stacy Robinson A report released Aug. 13 by the Department of Health and Human Services (HHS) has shined a...